Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2025-12-16 @ 11:35 PM
Study NCT ID:
NCT04697628
Status:
None
Last Update Posted:
2025-09-15 00:00:00
First Post:
2021-01-04 00:00:00
Brief Title:
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Sponsor:
Organization:
Seagen Inc.